- Home
- PRLD vs BGSF Comparison
PRLD vs BGSF Comparison
Compare PRLD & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- BGSF
- Stock Information
- Founded
- PRLD 2016
- BGSF 2007
- Country
- PRLD United States
- BGSF United States
- Employees
- PRLD N/A
- BGSF N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- BGSF Professional Services
- Sector
- PRLD Health Care
- BGSF Consumer Discretionary
- Exchange
- PRLD Nasdaq
- BGSF Nasdaq
- Market Cap
- PRLD 48.6M
- BGSF 47.7M
- IPO Year
- PRLD 2020
- BGSF N/A
- Fundamental
- Price
- PRLD $0.86
- BGSF $6.94
- Analyst Decision
- PRLD Strong Buy
- BGSF Strong Buy
- Analyst Count
- PRLD 2
- BGSF 1
- Target Price
- PRLD $4.50
- BGSF $9.00
- AVG Volume (30 Days)
- PRLD 219.3K
- BGSF 278.7K
- Earning Date
- PRLD 08-11-2025
- BGSF 08-06-2025
- Dividend Yield
- PRLD N/A
- BGSF N/A
- EPS Growth
- PRLD N/A
- BGSF N/A
- EPS
- PRLD N/A
- BGSF N/A
- Revenue
- PRLD $7,000,000.00
- BGSF $266,968,000.00
- Revenue This Year
- PRLD N/A
- BGSF $0.59
- Revenue Next Year
- PRLD N/A
- BGSF N/A
- P/E Ratio
- PRLD N/A
- BGSF N/A
- Revenue Growth
- PRLD N/A
- BGSF N/A
- 52 Week Low
- PRLD $0.61
- BGSF $2.91
- 52 Week High
- PRLD $6.80
- BGSF $9.06
- Technical
- Relative Strength Index (RSI)
- PRLD 48.56
- BGSF 66.23
- Support Level
- PRLD $0.78
- BGSF $5.28
- Resistance Level
- PRLD $0.88
- BGSF $7.65
- Average True Range (ATR)
- PRLD 0.07
- BGSF 0.53
- MACD
- PRLD -0.00
- BGSF 0.10
- Stochastic Oscillator
- PRLD 50.06
- BGSF 61.80
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.